Description

Chemclin Diagnostics Co., Ltd. is dedicated to the comprehensive process of researching, developing, manufacturing, and marketing clinical immunochemiluminescence diagnostic reagents and accompanying instruments. The company's product portfolio features two primary lines: the LiCA series of diagnostic reagents, which are built upon a photoinduced chemiluminescence method, and the CC series, comprising both reagents and instruments that leverage enzymatic chemiluminescence technology. These diagnostic solutions are primarily applied in identifying markers for infectious diseases, tumor indicators, thyroid hormones, reproductive endocrine hormones, myocardial conditions, and various inflammatory processes. The company was founded in 2007 and operates from its base in Beijing, China.